Alloreactive and autoimmune responses after allogeneic hematopoietic cell transplantation
can occur in nonclassical chronic graft-versus-host disease (chronic GVHD) tissues and …

Abstract Secondary autoimmune diseases (2ndADs), most frequently autoimmune
cytopenias (AICs), were first described after allogeneic hematopoietic stem cell …

Anemia after allogeneic hematopoietic stem cell transplantation (HSCT) can be immune or
non–immune mediated. Auto-or alloimmunity resulting from blood group incompatibility …

Cellular blood components and plasma-derived medicinal products (PDMPs) are obtained
from blood donated by volunteers. In a growing number of countries, in line with World …

Autoimmune manifestations after allogeneic hematopoietic stem cell transplantation
(AHSCT) are rare and poorly understood due to the complex interplay between the …

Immune phenomena are increasingly reported in myeloid neoplasms, and include
autoimmune cytopenias/diseases and immunodeficiency, either preceding or complicating …

Autoimmune haemolytic anaemia (AIHA) is a rare complication of allogeneic haematopoietic
stem cell transplantation (HSCT), observed with an incidence of 1–5%. Paediatric age …

The definition of autoimmune neutropenias (AIN) has been based on the demonstration of
autoantibodies directed to various epitopes on blood neutrophils. However, this definition is …

Abstract Background Autoimmune cytopenias (AICs) are rare, but serious complications of
allogeneic hematopoietic cell transplantation (allo‐HSCT). Procedure We performed a case …

Although modern clinical management strategies have improved the outcome of paediatric
patients with severe autoimmune and inflammatory diseases over recent decades, a …